TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fidia Spa ( (IT:FDA) ) has issued an update.
Fidia S.p.A. has announced the termination of employment with its CFO, Dr. Luca Carante, as part of a strategic move to strengthen its organizational structure. The company is actively seeking a new candidate for the CFO and Investor Relations Manager roles, with interim responsibilities being handled by the CEO and Chairman.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. is a global leader in the design, production, and marketing of high-performance integrated milling systems, primarily serving the automotive and aerospace sectors. With over 50 years of experience, the company offers comprehensive solutions for the entire milling process, including numerical controls, high-speed milling systems, and CAM software.
Average Trading Volume: 440,111
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.71M
Learn more about FDA stock on TipRanks’ Stock Analysis page.